Kendall Park, NJ, United States of America

Suketu Sanghvi

This inventor holds 30 USPTO granted patents and 21 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Par Pharmaceutical, Inc., Progenics Pharmaceuticals, Inc., Scienture, Inc.. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suketu Sanghvi. Retrieved from https://idiyas.com/inventor/suketu-sanghvi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 

% Patents Active = 83.3

 

 

Average Co-Inventor Count = 3.6

ph-index = 8

Forward Citations = 196(Granted Patents)


Company Filing History:


Years Active: 2009-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Epinephrine
Vasopressin
Methylnaltrexone
Liquid Formulations
Stable Formulations
Pharmaceuticals
Hypotension Treatment
Dosage Forms
Drug Delivery
Therapeutics
30 patents (USPTO):Explore Patents

Title: Suketu Sanghvi: A Pioneer in Pharmaceutical Innovations

Introduction: Suketu Sanghvi is a distinguished inventor based in Kendall Park, NJ, renowned for his significant contributions to the pharmaceutical industry. With an impressive portfolio of 28 patents, he has played a pivotal role in advancing medical formulations that address critical health issues.

Latest Patents: Among Suketu's latest patents are innovative epinephrine formulations designed as pharmaceutical compositions. These formulations encompass active agents, pH raising agents, antioxidants, and stabilizing agents, enhancing their effectiveness in administration and production processes. Additionally, he has developed vasopressin formulations aimed at treating hypotension, utilizing polymers as stabilizing agents to prolong the stability of peptide formulations at elevated temperatures. These inventions reflect his commitment to improving therapeutic outcomes through meticulous research and development.

Career Highlights: Suketu has built his career in esteemed companies such as Par Pharmaceutical, Inc. and Progenics Pharmaceuticals, Inc. His role in these organizations has been instrumental in leveraging his patent strategies to bring groundbreaking inventions to market.

Collaborations: Throughout his career, Suketu has collaborated with notable professionals like Matthew Kenney and Vinayagam Kannan. These partnerships have enriched his inventive endeavors, fostering an environment of shared expertise and knowledge in pharmaceuticals.

Conclusion: Suketu Sanghvi stands out as a luminary in the field of pharmaceutical innovations. His extensive patent portfolio and collaborative work exemplify his dedication to enhancing medical solutions and improving patient care. As the pharmaceutical landscape continues to evolve, the contributions of inventors like Suketu will unmistakably pave the way for future breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…